721 results on '"Oppelt, Peter"'
Search Results
2. Single day 14 serum hCG values allow prediction of viable pregnancy and are significantly higher in frozen as compared to fresh single blastocyst transfer
3. Prevention of peritoneal adhesions after gynecological surgery: a systematic review
4. Trends in ototoxicity monitoring among cisplatin-treated patients with cancer
5. Influence of basic knowledge about female health, physiology, and contraception on unintended pregnancies: an international multicenter survey among women in Austria, Germany and Switzerland
6. Tumors eines frühgeborenen Knaben
7. Birth Register for Deep Endometriosis (BiRDeE): first analysis and recommendations
8. Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries
9. Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance
10. Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trial
11. Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial
12. Predicting adverse outcomes in pregnant patients positive for SARS-CoV-2: a machine learning approach- a retrospective cohort study
13. Oncologic and Fertility Outcomes After Simple Trachelectomy in Women With Early Cervical Cancer
14. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
15. Classification and Clinical Staging of Endometriosis
16. Pregnancy and Obstetric Outcomes in Endometriosis
17. No suitable cut-off value of C-reactive protein for ruling out infection after cesarean section
18. Preliminary results of a phase 1, first-in-human, dose escalation study of the anti-CCR8 cytolytic antibody, CHS-114 (formerly SRF114) in patients with advanced solid tumors.
19. Bleeding pattern after medical management of early pregnancy loss with mifepristone–misoprostol and its prognostic value: a prospective observational cohort study
20. The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries
21. Retrospective Evaluation of C-reactive Protein for Ruling Out Infection After Cesarean Section.
22. Socioeconomic status as a risk factor for SARS-CoV-2 infection in pregnant women.
23. Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.
24. Ionophore application for artificial oocyte activation and its potential effect on morphokinetics: a sibling oocyte study
25. Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer
26. Minerals and the Menstrual Cycle: Impacts on Ovulation and Endometrial Health
27. Tumor of a prematurely born boy
28. A Systematic Review of the Treatment of Uterine Myomas Using Transcervical Ultrasound-Guided Radiofrequency Ablation with the Sonata System
29. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
30. Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial
31. Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial
32. Concurrent paclitaxel and radiation therapy for the treatment of cutaneous angiosarcoma
33. Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial
34. Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
35. Retrospective evaluation of attempted vaginal deliveries in dichorionic twin pregnancies
36. Biomarker screening in preeclampsia: an RNA-sequencing approach based on data from multiple studies
37. Retrospective evaluation of established cut-off values for the sFlt-1/PlGF ratio for predicting imminent delivery in preeclampsia patients
38. Großer, symptomatischer Adnexbefund in der Schwangerschaft
39. Does the Porter formula hold its promise? A weight estimation formula for macrosomic fetuses put to the test
40. Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial
41. Extrauteringravidität
42. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
43. Oncologic and fertility outcomes after simple trachelectomy in women with early cervical cancer
44. Supplementary Tables 1-4 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
45. Data from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
46. Supplementary Appendix 1 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
47. Supplementary Figure S1 from A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor
48. Predictors of acute throat or esophageal patient reported pain during radiation therapy for head and neck cancer
49. Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers
50. nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.